Journal profile · Multiple
TH Open
ISSN 2512-9465 · Georg Thieme Verlag KG · Germany
TH Open: CAS Zone 3 · Medicine (2026 Xinrui edition); fully open access; APC about USD 3,200; median 92 days to acceptance (71 articles, last 24 months); 36 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
TH Open is published by Georg Thieme Verlag KG and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Platelet Disorders and Treatments, together about 43.3% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine and Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Aims & Scope: TH Open is a fully open-access companion journal to Thrombosis and Haemostasis dedicated to advancing knowledge and practice in vascular biology and medicine. Our mission is to provide unrestricted access to high-quality, peer-reviewed research that supports clinical innovation and global collaboration. Target Readership: TH Open serves clinicians, and researchers worldwide who seek peer-reviewed information on vascular biology and medicine. Types of Articles Published: The journal publishes original basic research and clinical studies, review articles, letters to the editor, and case reports. Publication Frequency: TH Open publishes continuously online, ensuring rapid dissemination of accepted articles and immediate access to new research. Subject and Content Scope: The journal content spans a wide spectrum of topics: coagulation and fibrinolysis; cellular haemostasis and platelets; blood cells, inflammation and infection; endothelium and angiogenesis; cellular signaling and proteolysis; new technologies, diagnostic tools and drugs; stroke, systemic or venous thromboembolism, atherosclerosis and ischaemic disease.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venous Thromboembolism Diagnosis and ManagementMedicine21.6%
- Atrial Fibrillation Management and OutcomesMedicine12.6%
- Platelet Disorders and TreatmentsMedicine9.2%
- Blood Coagulation and Thrombosis MechanismsMedicine8.6%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine6.5%
- Hemophilia Treatment and ResearchMedicine4.9%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine4.2%
- COVID-19 Clinical Research StudiesMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2017
- 1.8Publisher website ·
- h-index
- 29OpenAlex ·
- i10-index
- 155OpenAlex ·
- 2-year mean citedness
- 1.48OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 29LetPub ·
Articles by year OpenAlex count · 510 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 46 | 46 | 2 |
| 2025 | 36 | 36 | 24 |
| 2024 | 36 | 36 | 149 |
| 2023 | 44 | 44 | 206 |
| 2022 | 56 | 56 | 369 |
| 2021 | 83 | 83 | 847 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
92 daysMedian, submission to acceptance · P25–P75 53 days – 132 days
- Acceptance to online
- median 25 days (71 articles)
- Submission to online
- median 124 days
- Sample
- 71 articles with submission and acceptance dates (77 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,875 / USD 3,200 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,500 / EUR 2,500 | — | — | |
| LetPub | USD 2,500 / EUR 2,500 | Yes | — | |
| Publisher website | EUR 3,015 / USD 3,355 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Georg Thieme Verlag KG
- Country or region
- Germany
- Language
- English
- ISSN
- 2512-9465
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about TH Open
What CAS zone is TH Open in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at TH Open?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 53–132 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index TH Open?
According to LetPub and DOAJ records, TH Open is indexed in ESCI and DOAJ. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is TH Open open access, and what is the APC?
TH Open is a fully open-access journal. APC about USD 3,200.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .